Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Mar 27 • 04:00PM ET

25.01

Dollar change -0.20
Percentage change -0.79	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: MRK JNJ ABBV BMY LLY GILD AMGN BIIB REGN VRTX

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	17.77	EPS (ttm)	1.41	Insider Own	0.04%	Shs Outstand	5.67B	Perf Week	-4.51%
Market Cap	141.84B	Forward P/E	8.24	EPS next Y	3.03	Insider Trans	0.80%	Shs Float	5.67B	Perf Month	-5.34%
Income	8.02B	PEG	-	EPS next Q	0.71	Inst Own	67.12%	Short Float	1.75%	Perf Quarter	-6.36%
Sales	63.63B	P/S	2.23	EPS this Y	-4.91%	Inst Trans	-0.47%	Short Ratio	2.22	Perf Half Y	-15.22%
Book/sh	15.56	P/B	1.61	EPS next Y	2.62%	ROA	3.65%	Short Interest	99.17M	Perf Year	-8.82%
Cash/sh	3.61	P/C	6.93	EPS next 5Y	-0.97%	ROE	9.05%	52W Range	24.48 - 31.54	Perf YTD	-5.73%
Dividend Est.	1.70 (6.79%)	P/FCF	14.42	EPS past 5Y	-13.25%	ROI	5.42%	52W High	-20.70%	Beta	0.64
Dividend TTM	1.69 (6.76%)	Quick Ratio	0.92	Sales past 5Y	17.19%	Gross Margin	66.76%	52W Low	2.17%	ATR (14)	0.52
Dividend Ex-Date	Jan 24, 2025	Current Ratio	1.17	EPS Y/Y TTM	272.80%	Oper. Margin	26.92%	RSI (14)	35.77	Volatility	1.93% 2.06%
Employees	81000	Debt/Eq	0.76	Sales Y/Y TTM	8.77%	Profit Margin	12.60%	Recom	2.29	Target Price	30.39
Option/Short	Yes / Yes	LT Debt/Eq	0.68	EPS Q/Q	112.15%	Payout	119.94%	Rel Volume	1.13	Prev Close	25.21
Sales Surprise	2.38%	EPS Surprise	33.59%	Sales Q/Q	24.66%	Earnings	Feb 04 BMO	Avg Volume	44.62M	Price	25.01
SMA20	-3.80%	SMA50	-4.21%	SMA200	-9.23%	Trades		Volume	50,618,130	Change	-0.79%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60
Dec-13-22	Upgrade	Goldman	Neutral → Buy	$47 → $60

Show Previous Ratings

Today 07:00PM	Pfizer: Value Play or Past Its Prime? (Motley Fool)
04:19PM	SCHD's Big Changes Impact The Dividend And Your Exposure (SeekingAlpha)
12:51PM	Pfizer Is Facing A First-Quarter Slowdown. Is Pfizer Stock Now A Sell? (Investor's Business Daily)
11:34AM	Merck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive (Zacks)
11:30AM	U.S. to end funding for child vaccines in developing countries, NY Times reports (TipRanks)
10:06AM	Loading…
10:06AM	GSK accuses Pfizer of delaying Covid vaccine result until after US election (The Telegraph)
06:45AM	Why Pfizer Is My Largest Healthcare Position (Motley Fool)
05:06AM	Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks (StockStory)
Mar-26-25 06:43PM	U.S. Prosecutors Probe Tip About Timing of Pfizer Vaccine (The Wall Street Journal)
06:00PM	Strategically Building A $100,000 Dividend Portfolio For Attractive Income And Strong Risk-Adjusted Returns (SeekingAlpha)
05:45PM	Here's Why Pfizer (PFE) Fell More Than Broader Market (Zacks)
03:25PM	Pfizer Stock Slips After Report on Vaccine Timing Probe (The Wall Street Journal)
12:31PM	5 Reasons To Buy Regenxbio Right Now (SeekingAlpha)
09:01AM	ViiV Healthcare Announces Reimbursement for APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP) under the Non-Insured Health Benefits (NIHB) Program (PR Newswire)
Mar-25-25 05:12PM	Pfizer: Undervalued Defensive Play (GuruFocus.com)
04:05PM	Loading…
04:05PM	Dexcom Appoints Jon Coleman as Chief Commercial Officer (Business Wire)
03:41PM	Pfizer Is Trading As If It's 2009 Again (SeekingAlpha)
06:47AM	5 Large Drug Stocks to Watch as Industry Recovers (Zacks)
02:20AM	Broadcom and Crown Castle in the Box have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Mar-24-25 04:19PM	Is Pfizer (PFE) The Best Affordable Stock To Buy According To Hedge Funds? (InsiderMonkey)
08:37AM	Pfizer Is a Dirt-Cheap High-Yield Stock, But Is It a Buy? (Zacks)
06:29AM	J&J to Invest $55B in United States to Boost Manufacturing, R&D (Zacks)
Mar-23-25 08:42PM	China promotes business potential to Apple, Pfizer and other US companies (Reuters)
01:56PM	Is Pfizer Inc. (PFE) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
Mar-22-25 06:44AM	Buying These Dirt-Cheap Stocks Could Be a Brilliant Move (Motley Fool)
06:02AM	Pfizer: Bulls Need To Check Out Its Graham P/E (SeekingAlpha)
Mar-21-25 09:00PM	Looking For Yields: Pfizer, Spire, And TriCo Bancshares Are Consistent Moneymakers (Benzinga)
05:37PM	Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster (SeekingAlpha)
04:13PM	Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio (Investor's Business Daily)
02:04PM	Alnylam challenges Pfizer and BridgeBio with FDA nod for ATTR-CM drug (Pharmaceutical Technology)
01:21PM	Loading…
01:21PM	Alnylam Stock Jumps After the FDA Approves Its Heart Drug (The Wall Street Journal)
01:13PM	Upgrading Beam Therapeutics: Promising BEAM-302 Data Opens Door For Durable Gene Therapy (SeekingAlpha)
12:26PM	Pharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A Deals (Zacks)
10:05AM	Alnylam Heart Drug Approval Sets Up Challenge With Pfizer (Bloomberg)
08:15AM	AstraZeneca deepens China investment; Editas loses CFO to Dyne (BioPharma Dive)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
Mar-20-25 06:13PM	Alnylam nabs key additional indication for Amvuttra (SeekingAlpha)
05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
03:00PM	GILD Stock Down on Report of Cut in HIV Prevention Spending (Zacks)
02:11PM	U.S. boosts bird flu response with another $100M in funds (SeekingAlpha)
12:30PM	Sanofi Inks $1.9B Deal With Dren Bio to Buy Autoimmune Disease Drug (Zacks)
11:15AM	Buy 4 Ideal 'Safer' February Dividends, Out Of 40 Choices From Readers (SeekingAlpha)
10:00AM	Trump Trade: Reciprocal tariffs still to start on April 2 (TipRanks)
09:45AM	3 Reasons Pfizer Stock Could Be a Steal of a Deal in 2025 (Motley Fool)
09:40AM	My Dividend Stock Portfolio: New February Dividend Record - 100 Holdings With 11 Buys (SeekingAlpha)
09:00AM	2 High-Yield Dividend Stocks That Are Bargain Buys Right Now (Motley Fool)
08:45AM	Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B (Zacks)
08:18AM	Pfizer sells 7.3% stake in Haleon for $3.3bn (Pharmaceutical Technology)
07:30AM	More Dividends, Less Drama: 3 Of My Favorite Dividend Stocks (5-7% Yield) (SeekingAlpha)
06:17AM	1 Reliable Dividend Stock You Can Buy Now and Hold at Least a Decade (Motley Fool)
Mar-19-25 05:45PM	Pfizer (PFE) Stock Dips While Market Gains: Key Facts (Zacks)
05:07PM	Immunovant: TED Data Sets Stage For Batoclimab Regulatory Filings Going Forward (SeekingAlpha)
10:49AM	Pfizer Inc. (PFE): The Most Undervalued Biotech Stock to Invest In (Insider Monkey)
09:40AM	Stocks to Watch Wednesday: Nvidia, Tencent, Pfizer, Haleon (The Wall Street Journal)
09:39AM	Pfizer Sells Final Haleon Shares for $3.2B, Ends Stake in Consumer Healthcare Giant (GuruFocus.com)
09:00AM	This Unstoppable Biotech Stock Just Became an Even Better Buy (Motley Fool)
07:30AM	3 Dividend Stocks to Buy for Reliable Passive Income (Fool)
04:41AM	Pfizer Wraps Up Haleon Exit With $3.3 Billion Stake Sale (Bloomberg)
03:26AM	Pfizer sells entire Haleon stake for $3.24 billion (Reuters)
Mar-18-25 06:02PM	Analyst Says Pfizer (PFE) Stock Will Move Too Fast to Catch (Insider Monkey)
12:54PM	Pfizer to sell entire Haleon stake (Reuters)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of April 29 Conference Call with Analysts (Business Wire)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
02:33AM	Pfizer Inc. (PFE): One of the Most Profitable Value Stocks to Buy Now (Insider Monkey)
Mar-17-25 01:51PM	Is Pfizer (PFE) the Most Undervalued S&P 500 Stock to Buy Now? (Insider Monkey)
09:02AM	3 Value Stocks in the Doghouse (StockStory)
05:00AM	Pfizer Has a New Playbook for Reviving Salesand Its Starting to Pay Off (The Wall Street Journal)
04:49AM	The Smartest Dividend Stocks to Buy With $150 Right Now (Motley Fool)
04:45AM	Pfizer Inc. (PFE): Among Top Dividend Contenders List (Insider Monkey)
Mar-14-25 12:15PM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
05:01AM	Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks (StockStory)
Mar-13-25 05:45PM	Pfizer (PFE) Stock Moves -0.43%: What You Should Know (Zacks)
01:36PM	Calls of the Day: Invitation Homes, Pfizer and Roblox (CNBC TV)
07:30AM	This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This Year (Motley Fool)
Mar-12-25 02:27PM	Is Pfizer Inc. (PFE) the Best Pharma Stock to Buy According to Hedge Funds? (Insider Monkey)
Mar-11-25 04:06PM	Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug (Investor's Business Daily)
02:21PM	Lawmakers demand answers from RFK Jr. over Trump dinners with pharma execs (Quartz)
11:43AM	Pfizer and Arvinass HER2-breast cancer drug extends PFS in certain patients (Clinical Trials Arena)
08:15AM	Merck opens $1B vaccine plant in North Carolina (BioPharma Dive)
07:45AM	Arvinas gets positive breast cancer data, but finds differentiation a hard sell (BioPharma Dive)
06:45AM	Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial (GlobeNewswire)
01:02AM	Q4 2024 Biontech SE Earnings Call (Thomson Reuters StreetEvents)
Mar-10-25 09:40AM	Is Pfizer Inc. (PFE) the Most Undervalued US Stock to Buy According to Hedge Funds? (Insider Monkey)
05:06AM	3 Reasons PFE is Risky and 1 Stock to Buy Instead (StockStory)
Mar-08-25 02:19PM	Is Pfizer Inc. (PFE) The Best Cheap Dividend Stock To Buy Right Now? (Insider Monkey)
11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
08:30AM	3 Top Dividend Stocks to Buy in March (Motley Fool)
Mar-07-25 04:04PM	Why Moderna Stock Has Surged 15% This Week Despite Mixed News (Investor's Business Daily)
12:47PM	Pfizer Appoints Ex-J&J Leader to Accelerate Weight Loss Solutions (GuruFocus.com)
11:55AM	Is Pfizer Stock A Buy After Nabbing A Quarterly Beat On Its Covid Products? (Investor's Business Daily)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
04:06AM	The Nasdaq Is Falling: 4 of the Safest Stocks to Buy Right Now (Motley Fool)
03:15AM	The Smartest Dividend Stocks to Buy With $2,000 Right Now (Motley Fool)
Mar-06-25 01:59PM	Final Trades: Pfizer, Paychex and the JEPI (CNBC TV)
11:31AM	Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound? (Zacks)
Mar-05-25 01:06PM	Why Moderna (MRNA) Stock Is Rallying Today (Insider Monkey)
01:05PM	Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute (GuruFocus.com)
10:02AM	German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent (Reuters)
09:45AM	What Trump's next batch of tariffs could mean for pharma industry (Yahoo Finance Video)
07:00AM	3 Ultra-Cheap Dividend Stocks to Buy Right Now (Motley Fool)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience